Vicore Pharma Holding AB (OSTO:VICO) Accumulated Depreciation : kr0.00 Mil (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Vicore Pharma Holding AB Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Vicore Pharma Holding AB's quarterly accumulated depreciation increased from Sep. 2024 (kr0.00 Mil) to Dec. 2024 (kr-0.15 Mil) but then stayed the same from Dec. 2024 (kr-0.15 Mil) to Mar. 2025 (kr0.00 Mil).

Vicore Pharma Holding AB's annual accumulated depreciation increased from Dec. 2022 (kr-0.09 Mil) to Dec. 2023 (kr-0.12 Mil) and increased from Dec. 2023 (kr-0.12 Mil) to Dec. 2024 (kr-0.15 Mil).

Vicore Pharma Holding AB Accumulated Depreciation Historical Data

The historical data trend for Vicore Pharma Holding AB's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicore Pharma Holding AB Accumulated Depreciation Chart

Vicore Pharma Holding AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated Depreciation

Get a 7-Day Free Trial

-0.03

-0.06

-0.09

-0.12

-0.15

Vicore Pharma Holding AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accumulated Depreciation	Get a 7-Day Free Trial															-	-	-	-0.15	-

Vicore Pharma Holding AB Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Vicore Pharma Holding AB Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Vicore Pharma Holding AB's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Vicore Pharma Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vicore Pharma Holding AB (OSTO:VICO) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kornhamnstorg 53, Stockholm, SWE, 111 27

Website

https://www.vicorepharma.com

Vicore Pharma Holding AB is a clinical-stage pharmaceutical company focused on severe lung diseases. The company is establishing a portfolio in respiratory diseases, including idiopathic pulmonary fibrosis (IPF). Its C21 is a small molecule angiotensin II type 2 receptor agonist (ATRAG) currently in phase 2b development for IPF. The company also has an investigational medical device in clinical development, namely, Almee, which is a digital therapeutic leveraging cognitive behavioral therapy created to address the psychological impact of living with pulmonary fibrosis.

Vicore Pharma Holding AB Headlines

No Headlines